chartexchange

PMV Pharmaceuticals Reports Third Quarter 2026 Financial Results and Corporate Highlights

GlobeNewswire Inc. | Nov 10, 2026 8:00 AM EST

PRINCETON, N.J., Nov. 10, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule therapies targeting p53, today reported financial results for the third quarter ended September 30, 2026, and provided a corporate update.

Read original article